Breadcrumb navigation

Pipeline

Breakthroughs in the making: We are tirelessly dedicated to developing medicines and vaccines that will benefit the world. Ambitious goals and a robust product pipeline allow us to achieve better outcomes for patients globally.

Indication

Preclinical

Phase I

Phase I/II

Phase II

Phase III

Partner

Personalized Neoantigen Vaccines

TG4050

Head & neck cancer

Ovarian cancer

NECVAX-NEO1

Basket solid tumors

Triple negative breast cancer

Indication

Preclinical

Phase I

Phase II

Phase III

Partner

Universal Infectious Vaccines

Therapeutic vaccine

Hepatitis B

Prophylactic vaccine

Betacorona

Prophylactic vaccine

Dengue fever, Malaria, Ebola (and many others)

Prophylactic vaccine

Influenza

For more details and collaboration opportunities